Cardiovascular MR imaging includes the complete anatomical display of the heart with CINE imaging of all phases of the heartbeat. Ultrafast techniques make breath hold three-dimensional coverage of the heart in different cardiac axes feasible. Cardiac MRI provides reliable anatomical and functional assessment of the heart and evaluation of myocardial viability and coronary artery disease by a noninvasive diagnostic imaging technique.
Cardiovascular MRI offers potential advantages over radioisotopic techniques because it provides superior spatial resolution, does not use ionizing radiation, has no imaging orientations constraints and contrast resolution better than echocardiography. It also offers direct visualization and characterization of atherosclerotic plaques and diseased vessel walls and surrounding tissues in cardiovascular research.
MRI perfusion approaches measure the alteration of regional myocardial magnetic properties after the intravenous injection of contrast agents and assess the extent of injury after a myocardial infarction and the presence of myocardial viability with a technique based on late enhancement. Extracellular MRI contrast agents, like Gd-DTPA, accumulate only in irreversibly damaged myocardium after a time period of at least 10 minutes.
This type of patients may also have an implanted cardiac stent, bypass or a cardiac pacemaker and special caution should be observed on the MRI safety and the contraindications. While a number of coronary stents have been tested and reported to be MRI compatible, coronary stents must be assessed on an individual basis, with the medical team weighing the risks and benefits of the MRI procedure.

Cardiac MRI overview:

Cardiovascular MRI has become one of the most effective noninvasive imaging techniques for almost all groups of heart and vascular disease.

The use of gas as a contrast medium has significant potential to avoid limitations of conventional contrast agents. Gases can transit smaller vascular conduits and can be injected through smaller and less traumatic access systems than liquids. Highly soluble gases (such as CO2) can be imaged as a bolus. Blood is displaced by the gas, with the result of negative image contrast.
Because gases are compressible, standard liquid injectors cannot be used. The design for a gasinjector should have the option for individual adaptation of blood flow rate, vessel diameter, pulse pressure, and heart rate.

From Toshiba America Medical Systems Inc.;
With its high-field strength, the Vantageâ„¢ delivers the clinical capabilities and image quality expected by cardiologists, while simultaneously offering patients a more comfortable and non-invasive option, said Dane Peshe, director, MRI Business Unit, Toshiba America Medical Systems. Vantageâ„¢ supports a full complement of cardiovascular imaging studies, ranging from stroke evaluation to peripheral vascular imaging. Additionally, the ultra short bore design offers patients a greater feeling of openness that reduces claustrophobic sensations, while Toshiba's exclusive, patented Pianissimoâ„¢ technology reduces scan noise by as much as 90 percent for a more pleasant experience.'

ABLAVAR™ (formerly named Vasovistâ„¢) is a blood pool agent for magnetic resonance angiography (MRA), which opens new medical imaging possibilities in the evaluation of aortoiliac occlusive disease (AIOD) in patients with suspected peripheral vascular disease.
ABLAVARâ„¢ binds reversibly to blood albumin, providing imaging with high spatial resolution up to 1 hour after injection, due to its high relaxivity and to the long lasting increased signal intensity of blood.
As with other contrast media: the possibility of serious or life-threatening anaphylactic or anaphylactoid reactions, including cardiovascular, respiratory and/or cutaneous manifestations, should always be considered.

WARNING:
NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m²), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.

See also Cardiovascular Imaging, Adverse Reaction, Molecular Imaging, and MRI Safety.

With this method irregular RR intervals in cardiac gating during cardiovascular imaging are rejected and then repeated to improve the image quality, whereby the cardiac frequency is used as a basis of the normal heart rate.
The RR interval window determines the percentage variation of the heart rate. Variations of the acquired data outside the window are rejected and not used in the image reconstruction. Also one interval after the arrhytmic beat will be rejected.
Arrhythmia rejection may be inappropriate for patients with certain pathologies, because if the RR interval is constant long, short, long, - all intervals would be rejected. Also a disadvantage is the time consume, but in some cases this function is mandatory, e.g. for diverse retrospective triggered sequences.